Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug;98(8):E204-E208.
doi: 10.1002/ajh.26960. Epub 2023 May 24.

Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts

Luca Lanino  1   2 , Francesco Restuccia  3 , Alessandra Perego  4 , Marta Ubezio  1   2 , Bruno Fattizzo  5 , Marta Riva  6 , Angela Consagra  7 , Pellegrino Musto  8 , Daniela Cilloni  9 , Esther Natalie Oliva  10 , Raffaele Palmieri  11 , Antonella Poloni  12 , Catello Califano  13 , Isabella Capodanno  14 , Federico Itri  15 , Chiara Elena  16 , Claudio Fozza  17 , Fabrizio Pane  18 , Anna Maria Pelizzari  19 , Massimo Breccia  20 , Francesco Di Bassiano  21 , Elena Crisà  22 , Dario Ferrero  23 , Valentina Giai  23 , Daniela Barraco  24 , Antonella Vaccarino  25 , Davide Griguolo  26 , Paola Minetto  27 , Martina Quintini  28 , Stefania Paolini  29 , Grazia Sanpaolo  30 , Mariarosaria Sessa  31 , Monica Bocchia  32 , Nicola Di Renzo  33 , Elisa Diral  34 , Livia Leuzzi  35 , Angelo Genua  36 , Attilio Guarini  37 , Alfredo Molteni  38 , Barbara Nicolino  39 , Ubaldo Occhini  40 , Giulia Rivoli  41 , Roberto Bono  42 , Anna Calvisi  43 , Andrea Castelli  44 , Eros Di Bona  45 , Ambra Di Veroli  46 , Felicetto Ferrara  47 , Luana Fianchi  48 , Sara Galimberti  49 , Daniele Grimaldi  50 , Monia Marchetti  51 , Marianna Norata  52 , Marco Frigeni  53 , Rosaria Sancetta  54 , Carmine Selleri  55 , Ilaria Tanasi  56 , Patrizia Tosi  57 , Mauro Turrini  58 , Laura Giordano  1   2 , Carlo Finelli  29 , Paolo Pasini  59 , Ilaria Naldi  7 , Valeria Santini  7 , Matteo Giovanni Della Porta  1   2 ; Fondazione Italiana Sindromi Mielodisplastiche (FISiM) Clinical network (https://www.fisimematologia.it/)
Affiliations
Free article

Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts

Luca Lanino et al. Am J Hematol. 2023 Aug.
Free article
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Cazzola M. Myelodysplastic syndromes. Longo DL, ed. N Engl J Med. 2020;383(14):1358-1374.
    1. Malcovati L, Hellström-Lindberg E, Bowen D, et al. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. Blood J Am Soc Hematol. 2013;122(17):2943-2964.
    1. Fenaux P, Platzbecker U, Mufti GJ, et al. Luspatercept in patients with lower-risk myelodysplastic syndromes. N Engl J Med. 2020;382(2):140-151.
    1. Farrukh F, Chetram D, Al-Kali A, et al. Real-world experience with luspatercept and predictors of response in myelodysplastic syndromes with ring sideroblasts. Am J Hematol. 2022;97(6):E210-E214.
    1. Gangat N, Chetram D, McCullough K, et al. Limited activity of luspatercept in myelofibrosis and myeloid neoplasms other than myelodysplastic syndromes with ring sideroblasts. Am J Hematol. 2022;97(12):E474-E477.

Publication types

MeSH terms

Associated data